Discover how SciY empowers scientists

FHS
May 31, 2024
2:47 pm

In this interview, NewsMedical talks to Santi Dominguez about the genesis of SCiY, and how the
consortium intends to empower scientists and researchers.

‘Mail-Order Bride’ or ‘Very Obese’: Bias in Resident Patient Handoffs

Stigmatizing language — words that perpetuated stereotypes or suggested blame or skepticism — was found in 23% of audio recordings of patient handoffs by residents

August 15, 2023

Regeneron hit with FDA rejection for blood cancer therapy – Pharmaceutical Technology

Share this article The biotech was pursuing indications in relapsed/refractory follicular lymphoma and in relapsed/refractory diffuse large B-cell lymphoma. Image credit: Shutterstock/Kateryna Kon. The US

March 26, 2024

Fresh from rebrand, Spyre Therapeutics raises $180M as it steers TLA1 program to clinic

Spyre Therapeutics is pulling in $180 million in a private placement just a couple of weeks after it rebranded from Aeglea BioTherapeutics. Spyre is selling

December 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.